Arkuda Therapeutics



Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease.

Duane Burnett
Co-founder, SVP & Discovery
Serena Hung
Head of Clinical Development
Andy Hu
Chief Business Officer
Joanne Bryce
Chief Financial Officer
Jean-François Blain
VP, Neurobiology
Raymond Hurst
VP, Pharmacology
Jim Lanter
Senior Director, Medicinal Chemistry
Marlene Friedlander
Executive Assistant to the CEO & Office Manager

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.